209 related articles for article (PubMed ID: 22707729)
1. Structure of nucleophosmin DNA-binding domain and analysis of its complex with a G-quadruplex sequence from the c-MYC promoter.
Gallo A; Lo Sterzo C; Mori M; Di Matteo A; Bertini I; Banci L; Brunori M; Federici L
J Biol Chem; 2012 Aug; 287(32):26539-48. PubMed ID: 22707729
[TBL] [Abstract][Full Text] [Related]
2. Synergic role of nucleophosmin three-helix bundle and a flanking unstructured tail in the interaction with G-quadruplex DNA.
Arcovito A; Chiarella S; Della Longa S; Di Matteo A; Lo Sterzo C; Scaglione GL; Federici L
J Biol Chem; 2014 Aug; 289(31):21230-41. PubMed ID: 24952945
[TBL] [Abstract][Full Text] [Related]
3. Nucleophosmin C-terminal leukemia-associated domain interacts with G-rich quadruplex forming DNA.
Federici L; Arcovito A; Scaglione GL; Scaloni F; Lo Sterzo C; Di Matteo A; Falini B; Giardina B; Brunori M
J Biol Chem; 2010 Nov; 285(48):37138-49. PubMed ID: 20858903
[TBL] [Abstract][Full Text] [Related]
4. Nucleophosmin mutations alter its nucleolar localization by impairing G-quadruplex binding at ribosomal DNA.
Chiarella S; De Cola A; Scaglione GL; Carletti E; Graziano V; Barcaroli D; Lo Sterzo C; Di Matteo A; Di Ilio C; Falini B; Arcovito A; De Laurenzi V; Federici L
Nucleic Acids Res; 2013 Mar; 41(5):3228-39. PubMed ID: 23328624
[TBL] [Abstract][Full Text] [Related]
5. G-quadruplex DNA recognition by nucleophosmin: new insights from protein dissection.
Scognamiglio PL; Di Natale C; Leone M; Poletto M; Vitagliano L; Tell G; Marasco D
Biochim Biophys Acta; 2014 Jun; 1840(6):2050-9. PubMed ID: 24576674
[TBL] [Abstract][Full Text] [Related]
6. Nucleophosmin mutations in acute myeloid leukemia: a tale of protein unfolding and mislocalization.
Federici L; Falini B
Protein Sci; 2013 May; 22(5):545-56. PubMed ID: 23436734
[TBL] [Abstract][Full Text] [Related]
7. c-MYC G-quadruplex binding by the RNA polymerase I inhibitor BMH-21 and analogues revealed by a combined NMR and biochemical Approach.
Musso L; Mazzini S; Rossini A; Castagnoli L; Scaglioni L; Artali R; Di Nicola M; Zunino F; Dallavalle S
Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):615-629. PubMed ID: 29229300
[TBL] [Abstract][Full Text] [Related]
8. Novel interaction of the Z-DNA binding domain of human ADAR1 with the oncogenic c-Myc promoter G-quadruplex.
Kang HJ; Le TV; Kim K; Hur J; Kim KK; Park HJ
J Mol Biol; 2014 Jul; 426(14):2594-604. PubMed ID: 24813121
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of an expanded porphyrin that has selectivity for the c-MYC G-quadruplex structure.
Seenisamy J; Bashyam S; Gokhale V; Vankayalapati H; Sun D; Siddiqui-Jain A; Streiner N; Shin-Ya K; White E; Wilson WD; Hurley LH
J Am Chem Soc; 2005 Mar; 127(9):2944-59. PubMed ID: 15740131
[TBL] [Abstract][Full Text] [Related]
10. Stabilization of G-quadruplex DNA with platinum(II) Schiff base complexes: luminescent probe and down-regulation of c-myc oncogene expression.
Wu P; Ma DL; Leung CH; Yan SC; Zhu N; Abagyan R; Che CM
Chemistry; 2009 Dec; 15(47):13008-21. PubMed ID: 19876976
[TBL] [Abstract][Full Text] [Related]
11. Structure-based design of platinum(II) complexes as c-myc oncogene down-regulators and luminescent probes for G-quadruplex DNA.
Wang P; Leung CH; Ma DL; Yan SC; Che CM
Chemistry; 2010 Jun; 16(23):6900-11. PubMed ID: 20437426
[TBL] [Abstract][Full Text] [Related]
12. Nucleophosmin in Its Interaction with Ligands.
Cela I; Di Matteo A; Federici L
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664415
[TBL] [Abstract][Full Text] [Related]
13. Interactions of the natural product (+)-avrainvillamide with nucleophosmin and exportin-1 Mediate the cellular localization of nucleophosmin and its AML-associated mutants.
Mukherjee H; Chan KP; Andresen V; Hanley ML; Gjertsen BT; Myers AG
ACS Chem Biol; 2015 Mar; 10(3):855-63. PubMed ID: 25531824
[TBL] [Abstract][Full Text] [Related]
14. Investigating actinomycin D binding to G-quadruplex, i-motif and double-stranded DNA in 27-nt segment of c-MYC gene promoter.
Niknezhad Z; Hassani L; Norouzi D
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():1188-93. PubMed ID: 26478420
[TBL] [Abstract][Full Text] [Related]
15. Solution structure of the biologically relevant G-quadruplex element in the human c-MYC promoter. Implications for G-quadruplex stabilization.
Ambrus A; Chen D; Dai J; Jones RA; Yang D
Biochemistry; 2005 Feb; 44(6):2048-58. PubMed ID: 15697230
[TBL] [Abstract][Full Text] [Related]
16. NM23-H2 may play an indirect role in transcriptional activation of c-myc gene expression but does not cleave the nuclease hypersensitive element III(1).
Dexheimer TS; Carey SS; Zuohe S; Gokhale VM; Hu X; Murata LB; Maes EM; Weichsel A; Sun D; Meuillet EJ; Montfort WR; Hurley LH
Mol Cancer Ther; 2009 May; 8(5):1363-77. PubMed ID: 19435876
[TBL] [Abstract][Full Text] [Related]
17. c-MYC promoter G-quadruplex formed at the 5'-end of NHE III1 element: insights into biological relevance and parallel-stranded G-quadruplex stability.
Mathad RI; Hatzakis E; Dai J; Yang D
Nucleic Acids Res; 2011 Nov; 39(20):9023-33. PubMed ID: 21795379
[TBL] [Abstract][Full Text] [Related]
18. Nemorubicin and doxorubicin bind the G-quadruplex sequences of the human telomeres and of the c-MYC promoter element Pu22.
Scaglioni L; Mondelli R; Artali R; Sirtori FR; Mazzini S
Biochim Biophys Acta; 2016 Jun; 1860(6):1129-38. PubMed ID: 26922833
[TBL] [Abstract][Full Text] [Related]
19. Structural insight for the recognition of G-quadruplex structure at human c-myc promoter sequence by flavonoid Quercetin.
Tawani A; Mishra SK; Kumar A
Sci Rep; 2017 Jun; 7(1):3600. PubMed ID: 28620169
[TBL] [Abstract][Full Text] [Related]
20. Structure-based optimization of FDA-approved drug methylene blue as a c-myc G-quadruplex DNA stabilizer.
Chan DS; Yang H; Kwan MH; Cheng Z; Lee P; Bai LP; Jiang ZH; Wong CY; Fong WF; Leung CH; Ma DL
Biochimie; 2011 Jun; 93(6):1055-64. PubMed ID: 21377506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
